The Sunday Read: ‘Ozempic Could Crush the Jun...

Nearly three weeks into the war in Iran, the United States and Israel have largely decimated the regime’s missile capacity, taken out key leaders and disrupted its central command. Yet, the regime in Iran has become more hardened and is wreaking more havoc than ever. Eric Schmitt ...  Show more

This past weekend, the chairman of the Federal Communications Commission threatened to revoke broadcasters’ licenses over their coverage of the war in Iran. Last month, Stephen Colbert said he had to drop an interview with a Senate candidate because of F.C.C. guidance that target ...  Show more

Snack-food companies have long shown their adaptability to changing diets. How could the rise of appetite-suppressing drugs and fears about ultra-processed foods change the food we consume? How hearing aids and other lifestyle choices can reduce your risk of dementia (11:00). And ...  Show more

DATA: https://www.leefang.com/p/sugary-soda-industrys-covert-influencer https://www.heart.org/en/healthy-living/company-collaboration/food-system-strategy/aha-industry-nutrition-forum/industry-nutrition-forum-members

Most people know that the Americ ...

Karen Andersen, biotechnology strategist for Morningstar Research Services, discusses what GLP-1 drugs’ demand means for the biopharma industry’s five-year outlook. And whether the weight-loss drugs pose a threat to snack food stocks.

Why GLP-1 Drugs Are in Demand 

The junk food industry is facing a major shake-up as consumer habits shift, weight-loss drugs like Ozempic gain traction, and government intervention ramps up. From declining snack sales at PepsiCo and Mondelez to Robert F. Kennedy Jr.’s crackdown on artificial additives and j ...